Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type II cuticular Hb5 (KRT85) is a member of the type II keratin family, which consists of basic proteins forming intermediate filaments in epithelial cells. KRT85 is mainly expressed in hair and nail-forming tissues, where it heterodimerizes with type I keratins to assemble the structural cytoskeleton necessary for mechanical strength and resilience. KRT85 is produced in the keratinizing cuticular cells of human hair and forms filaments together with acidic keratin partners (such as K35 and K31) in specific regions of the hair matrix and cortex. Mutations in this gene are associated with diseases affecting hair and nail formation such as ectodermal dysplasia 4 (hair/nail type) and ichthyosis. KRT85 is not recognized as a therapeutic target, receptor, enzyme, transporter, or signaling molecule but plays a crucial structural role in skin appendages.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type II cuticular Hb5 (KRT85).